Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray

Phase 1

Conditions: SARS-CoV-2 Acute Respiratory Disease
COVID-19

Interventions: Biological: Gam-COVID-Vac
Other: Placebo

First Posted Date: 2022-02-21

Last Posted Date: 2022-03-08

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 400

Registration Number: NCT05248373

Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac

Phase 3

Recruiting

Conditions: Tuberculosis

Interventions: Biological: Placebo
Biological: GamTBvac

First Posted Date: 2021-07-23

Last Posted Date: 2022-11-30

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 7180

Registration Number: NCT04975737

Locations: 🇷🇺
City hospital #40, Saint Petersburg, Russian Federation

Study of Gam-COVID-Vac in Adolescents

Phase 2

Conditions: Covid19
Vaccine Preventable Disease

Interventions: Biological: Gam-COVID-vac M
Biological: Placebo

First Posted Date: 2021-07-08

Last Posted Date: 2021-09-16

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 3000

Registration Number: NCT04954092

Locations: 🇷🇺
Children's City Clinical Hospital named after Z.A. Bashlyaeva of the Moscow Department of Health, Moscow, Russian Federation
🇷🇺
Morozovskaya Children's City Clinical Hospital of the Moscow Department of Health, Moscow, Russian Federation

Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light

Phase 3

Conditions: COVID-19 Prevention

Interventions: Other: Placebo
Biological: Sputnik Light

First Posted Date: 2021-02-05

Last Posted Date: 2021-02-21

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 6000

Registration Number: NCT04741061

Locations: 🇷🇺
Federal state budgetary educational Institution for Higher Education "Saratov State Medical University named after V.I. Razumovskiy" Ministry of Health of Russian Federation, Saratov, Russian Federation
🇷🇺
State Budgetary Healthcare Institution, Moscow, Consultation and Diagnosis Polyclinic No. 121, Moscow Healthcare Department, Moscow, Russian Federation
🇷🇺
State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 210, Moscow Healthcare Department, Moscow, Russian Federation

and more 12 locations

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Phase 1

Conditions: Ebola Virus Disease

Interventions: Drug: Gamezumab

First Posted Date: 2021-01-22

Last Posted Date: 2021-02-18

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 25

Registration Number: NCT04717830

Locations: 🇷🇺
Research Institute of Influenza, Sankt-Peterburg, Russian Federation

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Phase 1

Conditions: COVID-19 Prevention

Interventions: Biological: Sputnik Light

First Posted Date: 2021-01-19

Last Posted Date: 2021-02-02

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 110

Registration Number: NCT04713488

Locations: 🇷🇺
ECO-Safety, Sankt Peterburg, Russian Federation

A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE

Phase 3

Conditions: SARS-CoV Infection
Covid19

Interventions: Biological: Gam-COVID-Vac
Other: placebo

First Posted Date: 2020-12-07

Last Posted Date: 2020-12-07

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 1000

Registration Number: NCT04656613

Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela

Phase 3

Conditions: Covid19

Interventions: Biological: Gam-COVID-Vac
Biological: Placebo

First Posted Date: 2020-11-24

Last Posted Date: 2020-11-24

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 2000

Registration Number: NCT04642339

The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older

Phase 2

Conditions: Coronavirus Infection

Interventions: Biological: Gam-COVID-Vac

First Posted Date: 2020-10-14

Last Posted Date: 2021-01-22

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 110

Registration Number: NCT04587219

Locations: 🇷🇺
Federal state budgetary institution "Central clinical hospital with polyclinic" Of the office Of the President of the Russian Federation, Moscow, Russian Federation

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus

Phase 3

Conditions: Covid19

Interventions: Biological: Gam-COVID-Vac
Other: Placebo

First Posted Date: 2020-09-25

Last Posted Date: 2020-12-02

Lead Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Target Recruit Count: 100

Registration Number: NCT04564716

Locations: 🇧🇾
Health Institution "19th Central Regional Polyclinic of the Pervomaysk district of Minsk", Minsk, Belarus
🇧🇾
Health Institution "5th City Clinical Polyclinic of Minsk", Minsk, Belarus
🇧🇾
Health Institution "14th Central Regional Polyclinic of the Partisan district of Minsk", Minsk, Belarus

and more 5 locations

Home Terms & Conditions Privacy Policy